Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$119.44M
Total Bought:
$72.94M
Total Sold:
$77.15M
Net Transaction:
-$4.21M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Soleno Therapeutics Inc178,819302,483+123,664$14.98M$20.45M17.12%+$5.47M
Madrigal Pharmaceuticals, Inc.(MDGL)032,662+32,662$0$14.98M12.54%+$14.98M
Atai Beckley NvSHS02,287,005+2,287,005$0$12.10M10.13%+$12.10M
Ascendis Pharma A/SADR(ASND)051,080+51,080$0$10.16M8.50%+$10.16M
LENZ Therapeutics, Inc.(LENZ)343,322175,363-167,959$10.06M$8.17M6.84%-$1.89M
Taysha Gene Therapies, Inc.(TSHA)01,898,112+1,898,112$0$6.21M5.20%+$6.21M
Amylyx Pharmaceuticals, Inc.(AMLX)0437,391+437,391$0$5.94M4.98%+$5.94M
COMPASS Pathways plcADS(CMPS)1,485,0001,026,382-458,618$4.16M$5.88M4.92%+$1.72M
Eupraxia Pharmaceuticals Inc.(EPRX)0915,000+915,000$0$5.40M4.52%+$5.40M
Monopar Therapeutics Inc.(MNPR)34,53764,455+29,918$1.24M$5.26M4.41%+$4.03M
Arcutis Biotherapeutics, Inc.(ARQT)0233,220+233,220$0$4.40M3.68%+$4.40M
Mind Medicine Mindmed Inc726,172361,444-364,728$4.71M$4.26M3.57%-$451.4K
Tarsus Pharmaceuticals, Inc.(TARS)121,18270,778-50,404$4.91M$4.21M3.52%-$702.7K
Solid Biosciences Inc724,000549,182-174,818$3.53M$3.39M2.84%-$137.4K
Promis Neurosciences Inc1,334,4286,233,497+4,899,069$645.6K$2.65M2.22%+$2.00M
Avalo Therapeutics, Inc.(AVTX)0178,100+178,100$0$2.26M1.90%+$2.26M
Tectonic Therapeutic, Inc.(TECX)163,683138,595-25,088$3.25M$2.17M1.82%-$1.08M
Whitehawk Therapeutics, Inc.(WHWK)817,939817,9390$1.53M$1.55M1.30%+$24.5K
Atyr Pharma Inc287,7200-287,720$1.46M$0—-$1.46M
Ultragenyx Pharmaceutical InCALL
CALL
1,6000-1,600$5.82M$0—-$5.82M
Avidity Biosciences Inc132,7440-132,744$3.77M$0—-$3.77M
Centessa Pharmaceuticals PlcADS293,9860-293,986$3.86M$0—-$3.86M
Enliven Therapeutics Inc281,3940-281,394$5.64M$0—-$5.64M
Geron Corporation(GERN)3,251,4750-3,251,475$4.58M$0—-$4.58M
Insmed Incorporated(INSM)47,7100-47,710$4.80M$0—-$4.80M
Korro Bio, Inc.(KRRO)154,2230-154,223$1.93M$0—-$1.93M
Lexeo Therapeutics, Inc.(LXEO)867,3020-867,302$3.49M$0—-$3.49M
Merus N V140,2080-140,208$7.37M$0—-$7.37M
ORIC Pharmaceuticals, Inc.(ORIC)485,6290-485,629$4.93M$0—-$4.93M
Praxis Precision Medicines, Inc.(PRAX)80,8800-80,880$3.40M$0—-$3.40M
Replimune Group, Inc.(REPL)528,4910-528,491$4.91M$0—-$4.91M
Verona Pharma PlcADS160,7010-160,701$15.20M$0—-$15.20M
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q3 2025 | TickerTrail